Universidade Federal de Goias
Quick facts
Marketed products
- Midazolam, ketamine · Anesthesia / Sedation
This is a combination of midazolam (a benzodiazepine GABA-A receptor agonist) and ketamine (an NMDA receptor antagonist) used together for sedation and anesthesia. - Oral ketamine · Psychiatry, Pain Management, Anesthesia
Ketamine is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor that blocks glutamate signaling in the central nervous system. - Reinforced vaccination schedule · Immunology
A reinforced vaccination schedule enhances immune response by administering vaccine doses at optimized intervals to maximize antibody production and immunological memory. - Standard vaccination schedule · Immunology
A standard vaccination schedule stimulates the immune system to produce antibodies and cellular immunity against specific infectious diseases through sequential administration of vaccines.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Universidade Federal de Goias
What are Universidade Federal de Goias's marketed drugs?
Top marketed products include Midazolam, ketamine, Oral ketamine, Reinforced vaccination schedule, Standard vaccination schedule.
Related
- Midazolam, ketamine · Anesthesia / Sedation
- Oral ketamine · Psychiatry, Pain Management, Anesthesia
- Reinforced vaccination schedule · Immunology
- Standard vaccination schedule · Immunology
- Sector hub: All tracked pharma companies